Search Results

You searched for : multiplesclerosis

	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
	FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
	USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
	Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
	Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
	Zydus Cadila receives final approval for Dimethyl Fumarate Capsules Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Cancer on the Menu: How Excess Salt is Quietly Killing Your StomachDecember 03, 2024
	Breaking Barriers: Honouring the International Day of Persons with Disabilities December 03, 2024
	Invisible Threat: How Air Pollution is Impacting Pregnancies and Shaping Future GenerationsDecember 03, 2024
	Medanta Gurugram successfully treats ‘rarest of rare’ lymph node cancer resistant to other drugs using CAR-T Cell TherapyDecember 03, 2024
	Nonin Medical secures FDA clearance for its over-the-counter fingertip pulse oximeter, accurate for patients of all skin colorsDecember 02, 2024
	ALARM 2024: Amrita Leads the Fight Against Antimicrobial ResistanceDecember 02, 2024
	Coral adaptation unlikely to keep pace with global warmingDecember 02, 2024
	Reaching the unreached to find missing TB casesDecember 02, 2024
	Sip Smart: Why Changing Your Water Habits Can Change Your LifeNovember 28, 2024
	Can Your Fingers Predict How Much You Drink? New Study ExplainsNovember 28, 2024
	India Leads Global Medical Tourism with 8% Share; PSRI Sets New Benchmarks with nearly 15% International Patient BaseNovember 28, 2024
	Medicines save lives but not when they stop workingNovember 28, 2024
	A total of 340 Children Participated in the Painting Competition Organized by Asian HospitalNovember 28, 2024
	The Standing Desk Myth: Is Sitting Actually Healthier?November 27, 2024
	How Cancer Outsmarts Chemotherapy: The Hidden Metabolic GameNovember 27, 2024
	Aakash Healthcare Saves life of a 61-year-old Women through Timely Neuro-intervention with a multi-disciplinary management of StrokeNovember 27, 2024
	Breakfast Wars: Why Men and Women Should Eat DifferentlyNovember 27, 2024
	Only 10% of Businesses Are Ready to Become Experience-Orchestrated, Highlighting Lack of PersonalisationNovember 27, 2024
	Investors Think Safe, but Act Bold: MyFi Report Exposes Risk Tolerance Mismatch November 27, 2024
	Indkal Technologies Redefines Luxury Home Entertainment with Acer M Series Hybrid MiniLED TelevisionsNovember 27, 2024

Search Results

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients

USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera

Zydus Cadila receives final approval for Dimethyl Fumarate Capsules

Trending Now